Global Swine Vaccines Market Analysis and Forecast 2024-2030
The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.
Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.
Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.
According to APO Research, The global Swine Vaccines market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
China is the largest region of Swine Vaccines, with a share more than 40%, followed by Europe and North America, etc. Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC and Tecon are the top 5 manufacturers of industry, and they had a more than 55% combined market share.
This report presents an overview of global market for Swine Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Swine Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Swine Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Swine Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Swine Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Swine Vaccines sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC, Tecon, Zoetis, Ceva, Hile Bio and Chopper Biology, etc.
Swine Vaccines segment by Company
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Swine Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Swine Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Swine Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Swine Vaccines sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Chapter 14: The main concluding insights of the report.
Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.
Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.
According to APO Research, The global Swine Vaccines market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
China is the largest region of Swine Vaccines, with a share more than 40%, followed by Europe and North America, etc. Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC and Tecon are the top 5 manufacturers of industry, and they had a more than 55% combined market share.
This report presents an overview of global market for Swine Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Swine Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Swine Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Swine Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Swine Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Swine Vaccines sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC, Tecon, Zoetis, Ceva, Hile Bio and Chopper Biology, etc.
Swine Vaccines segment by Company
- Merck
- Boehringer Ingelheim
- Jinyu Bio-Technology
- CAHIC
- Tecon
- Zoetis
- Ceva
- Hile Bio
- Chopper Biology
- WINSUN
- Hipra
- Ringpu Biology
- ChengDu Tecbond
- DHN
- CAVAC
- Virbac
- HVRI
- Bioveta
- CSF Vaccines
- FMD Vaccines
- Porcine Circovirus Vaccines
- PRRS Vaccines
- Others
- Government Tender
- Market Sales
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Swine Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Swine Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Swine Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Swine Vaccines sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Chapter 14: The main concluding insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Swine Vaccines Market by Type
1.2.1 Global Swine Vaccines Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 CSF Vaccines
1.2.3 FMD Vaccines
1.2.4 Porcine Circovirus Vaccines
1.2.5 PRRS Vaccines
1.2.6 Others
1.3 Swine Vaccines Market by Application
1.3.1 Global Swine Vaccines Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 SWINE VACCINES MARKET DYNAMICS
2.1 Swine Vaccines Industry Trends
2.2 Swine Vaccines Industry Drivers
2.3 Swine Vaccines Industry Opportunities and Challenges
2.4 Swine Vaccines Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Swine Vaccines Revenue Estimates and Forecasts (2019-2030)
3.2 Global Swine Vaccines Revenue by Region
3.2.1 Global Swine Vaccines Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Swine Vaccines Revenue by Region (2019-2024)
3.2.3 Global Swine Vaccines Revenue by Region (2025-2030)
3.2.4 Global Swine Vaccines Revenue Market Share by Region (2019-2030)
3.3 Global Swine Vaccines Sales Estimates and Forecasts 2019-2030
3.4 Global Swine Vaccines Sales by Region
3.4.1 Global Swine Vaccines Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Swine Vaccines Sales by Region (2019-2024)
3.4.3 Global Swine Vaccines Sales by Region (2025-2030)
3.4.4 Global Swine Vaccines Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Swine Vaccines Revenue by Manufacturers
4.1.1 Global Swine Vaccines Revenue by Manufacturers (2019-2024)
4.1.2 Global Swine Vaccines Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Swine Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Swine Vaccines Sales by Manufacturers
4.2.1 Global Swine Vaccines Sales by Manufacturers (2019-2024)
4.2.2 Global Swine Vaccines Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Swine Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Swine Vaccines Sales Price by Manufacturers (2019-2024)
4.4 Global Swine Vaccines Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Swine Vaccines Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Swine Vaccines Manufacturers, Product Type & Application
4.7 Global Swine Vaccines Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Swine Vaccines Market CR5 and HHI
4.8.2 2023 Swine Vaccines Tier 1, Tier 2, and Tier
5 SWINE VACCINES MARKET BY TYPE
5.1 Global Swine Vaccines Revenue by Type
5.1.1 Global Swine Vaccines Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Swine Vaccines Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Swine Vaccines Revenue Market Share by Type (2019-2030)
5.2 Global Swine Vaccines Sales by Type
5.2.1 Global Swine Vaccines Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Swine Vaccines Sales by Type (2019-2030) & (M Doses)
5.2.3 Global Swine Vaccines Sales Market Share by Type (2019-2030)
5.3 Global Swine Vaccines Price by Type
6 SWINE VACCINES MARKET BY APPLICATION
6.1 Global Swine Vaccines Revenue by Application
6.1.1 Global Swine Vaccines Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Swine Vaccines Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Swine Vaccines Revenue Market Share by Application (2019-2030)
6.2 Global Swine Vaccines Sales by Application
6.2.1 Global Swine Vaccines Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Swine Vaccines Sales by Application (2019-2030) & (M Doses)
6.2.3 Global Swine Vaccines Sales Market Share by Application (2019-2030)
6.3 Global Swine Vaccines Price by Application
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Comapny Information
7.1.2 Merck Business Overview
7.1.3 Merck Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Merck Swine Vaccines Product Portfolio
7.1.5 Merck Recent Developments
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Comapny Information
7.2.2 Boehringer Ingelheim Business Overview
7.2.3 Boehringer Ingelheim Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Boehringer Ingelheim Swine Vaccines Product Portfolio
7.2.5 Boehringer Ingelheim Recent Developments
7.3 Jinyu Bio-Technology
7.3.1 Jinyu Bio-Technology Comapny Information
7.3.2 Jinyu Bio-Technology Business Overview
7.3.3 Jinyu Bio-Technology Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Jinyu Bio-Technology Swine Vaccines Product Portfolio
7.3.5 Jinyu Bio-Technology Recent Developments
7.4 CAHIC
7.4.1 CAHIC Comapny Information
7.4.2 CAHIC Business Overview
7.4.3 CAHIC Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 CAHIC Swine Vaccines Product Portfolio
7.4.5 CAHIC Recent Developments
7.5 Tecon
7.5.1 Tecon Comapny Information
7.5.2 Tecon Business Overview
7.5.3 Tecon Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Tecon Swine Vaccines Product Portfolio
7.5.5 Tecon Recent Developments
7.6 Zoetis
7.6.1 Zoetis Comapny Information
7.6.2 Zoetis Business Overview
7.6.3 Zoetis Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Zoetis Swine Vaccines Product Portfolio
7.6.5 Zoetis Recent Developments
7.7 Ceva
7.7.1 Ceva Comapny Information
7.7.2 Ceva Business Overview
7.7.3 Ceva Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Ceva Swine Vaccines Product Portfolio
7.7.5 Ceva Recent Developments
7.8 Hile Bio
7.8.1 Hile Bio Comapny Information
7.8.2 Hile Bio Business Overview
7.8.3 Hile Bio Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Hile Bio Swine Vaccines Product Portfolio
7.8.5 Hile Bio Recent Developments
7.9 Chopper Biology
7.9.1 Chopper Biology Comapny Information
7.9.2 Chopper Biology Business Overview
7.9.3 Chopper Biology Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Chopper Biology Swine Vaccines Product Portfolio
7.9.5 Chopper Biology Recent Developments
7.10 WINSUN
7.10.1 WINSUN Comapny Information
7.10.2 WINSUN Business Overview
7.10.3 WINSUN Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 WINSUN Swine Vaccines Product Portfolio
7.10.5 WINSUN Recent Developments
7.11 Hipra
7.11.1 Hipra Comapny Information
7.11.2 Hipra Business Overview
7.11.3 Hipra Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Hipra Swine Vaccines Product Portfolio
7.11.5 Hipra Recent Developments
7.12 Ringpu Biology
7.12.1 Ringpu Biology Comapny Information
7.12.2 Ringpu Biology Business Overview
7.12.3 Ringpu Biology Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 Ringpu Biology Swine Vaccines Product Portfolio
7.12.5 Ringpu Biology Recent Developments
7.13 ChengDu Tecbond
7.13.1 ChengDu Tecbond Comapny Information
7.13.2 ChengDu Tecbond Business Overview
7.13.3 ChengDu Tecbond Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.13.4 ChengDu Tecbond Swine Vaccines Product Portfolio
7.13.5 ChengDu Tecbond Recent Developments
7.14 DHN
7.14.1 DHN Comapny Information
7.14.2 DHN Business Overview
7.14.3 DHN Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.14.4 DHN Swine Vaccines Product Portfolio
7.14.5 DHN Recent Developments
7.15 CAVAC
7.15.1 CAVAC Comapny Information
7.15.2 CAVAC Business Overview
7.15.3 CAVAC Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.15.4 CAVAC Swine Vaccines Product Portfolio
7.15.5 CAVAC Recent Developments
7.16 Virbac
7.16.1 Virbac Comapny Information
7.16.2 Virbac Business Overview
7.16.3 Virbac Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.16.4 Virbac Swine Vaccines Product Portfolio
7.16.5 Virbac Recent Developments
7.17 HVRI
7.17.1 HVRI Comapny Information
7.17.2 HVRI Business Overview
7.17.3 HVRI Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.17.4 HVRI Swine Vaccines Product Portfolio
7.17.5 HVRI Recent Developments
7.18 Bioveta
7.18.1 Bioveta Comapny Information
7.18.2 Bioveta Business Overview
7.18.3 Bioveta Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.18.4 Bioveta Swine Vaccines Product Portfolio
7.18.5 Bioveta Recent Developments
8 NORTH AMERICA
8.1 North America Swine Vaccines Market Size by Type
8.1.1 North America Swine Vaccines Revenue by Type (2019-2030)
8.1.2 North America Swine Vaccines Sales by Type (2019-2030)
8.1.3 North America Swine Vaccines Price by Type (2019-2030)
8.2 North America Swine Vaccines Market Size by Application
8.2.1 North America Swine Vaccines Revenue by Application (2019-2030)
8.2.2 North America Swine Vaccines Sales by Application (2019-2030)
8.2.3 North America Swine Vaccines Price by Application (2019-2030)
8.3 North America Swine Vaccines Market Size by Country
8.3.1 North America Swine Vaccines Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Swine Vaccines Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Swine Vaccines Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Swine Vaccines Market Size by Type
9.1.1 Europe Swine Vaccines Revenue by Type (2019-2030)
9.1.2 Europe Swine Vaccines Sales by Type (2019-2030)
9.1.3 Europe Swine Vaccines Price by Type (2019-2030)
9.2 Europe Swine Vaccines Market Size by Application
9.2.1 Europe Swine Vaccines Revenue by Application (2019-2030)
9.2.2 Europe Swine Vaccines Sales by Application (2019-2030)
9.2.3 Europe Swine Vaccines Price by Application (2019-2030)
9.3 Europe Swine Vaccines Market Size by Country
9.3.1 Europe Swine Vaccines Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Swine Vaccines Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Swine Vaccines Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Swine Vaccines Market Size by Type
10.1.1 China Swine Vaccines Revenue by Type (2019-2030)
10.1.2 China Swine Vaccines Sales by Type (2019-2030)
10.1.3 China Swine Vaccines Price by Type (2019-2030)
10.2 China Swine Vaccines Market Size by Application
10.2.1 China Swine Vaccines Revenue by Application (2019-2030)
10.2.2 China Swine Vaccines Sales by Application (2019-2030)
10.2.3 China Swine Vaccines Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Swine Vaccines Market Size by Type
11.1.1 Asia Swine Vaccines Revenue by Type (2019-2030)
11.1.2 Asia Swine Vaccines Sales by Type (2019-2030)
11.1.3 Asia Swine Vaccines Price by Type (2019-2030)
11.2 Asia Swine Vaccines Market Size by Application
11.2.1 Asia Swine Vaccines Revenue by Application (2019-2030)
11.2.2 Asia Swine Vaccines Sales by Application (2019-2030)
11.2.3 Asia Swine Vaccines Price by Application (2019-2030)
11.3 Asia Swine Vaccines Market Size by Country
11.3.1 Asia Swine Vaccines Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Swine Vaccines Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Swine Vaccines Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Swine Vaccines Market Size by Type
12.1.1 MEALA Swine Vaccines Revenue by Type (2019-2030)
12.1.2 MEALA Swine Vaccines Sales by Type (2019-2030)
12.1.3 MEALA Swine Vaccines Price by Type (2019-2030)
12.2 MEALA Swine Vaccines Market Size by Application
12.2.1 MEALA Swine Vaccines Revenue by Application (2019-2030)
12.2.2 MEALA Swine Vaccines Sales by Application (2019-2030)
12.2.3 MEALA Swine Vaccines Price by Application (2019-2030)
12.3 MEALA Swine Vaccines Market Size by Country
12.3.1 MEALA Swine Vaccines Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Swine Vaccines Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Swine Vaccines Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Swine Vaccines Value Chain Analysis
13.1.1 Swine Vaccines Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Swine Vaccines Production Mode & Process
13.2 Swine Vaccines Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Swine Vaccines Distributors
13.2.3 Swine Vaccines Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
1.1 Product Definition
1.2 Swine Vaccines Market by Type
1.2.1 Global Swine Vaccines Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 CSF Vaccines
1.2.3 FMD Vaccines
1.2.4 Porcine Circovirus Vaccines
1.2.5 PRRS Vaccines
1.2.6 Others
1.3 Swine Vaccines Market by Application
1.3.1 Global Swine Vaccines Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Government Tender
1.3.3 Market Sales
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 SWINE VACCINES MARKET DYNAMICS
2.1 Swine Vaccines Industry Trends
2.2 Swine Vaccines Industry Drivers
2.3 Swine Vaccines Industry Opportunities and Challenges
2.4 Swine Vaccines Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Swine Vaccines Revenue Estimates and Forecasts (2019-2030)
3.2 Global Swine Vaccines Revenue by Region
3.2.1 Global Swine Vaccines Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Swine Vaccines Revenue by Region (2019-2024)
3.2.3 Global Swine Vaccines Revenue by Region (2025-2030)
3.2.4 Global Swine Vaccines Revenue Market Share by Region (2019-2030)
3.3 Global Swine Vaccines Sales Estimates and Forecasts 2019-2030
3.4 Global Swine Vaccines Sales by Region
3.4.1 Global Swine Vaccines Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Swine Vaccines Sales by Region (2019-2024)
3.4.3 Global Swine Vaccines Sales by Region (2025-2030)
3.4.4 Global Swine Vaccines Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Swine Vaccines Revenue by Manufacturers
4.1.1 Global Swine Vaccines Revenue by Manufacturers (2019-2024)
4.1.2 Global Swine Vaccines Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Swine Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Swine Vaccines Sales by Manufacturers
4.2.1 Global Swine Vaccines Sales by Manufacturers (2019-2024)
4.2.2 Global Swine Vaccines Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Swine Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Swine Vaccines Sales Price by Manufacturers (2019-2024)
4.4 Global Swine Vaccines Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Swine Vaccines Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Swine Vaccines Manufacturers, Product Type & Application
4.7 Global Swine Vaccines Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Swine Vaccines Market CR5 and HHI
4.8.2 2023 Swine Vaccines Tier 1, Tier 2, and Tier
5 SWINE VACCINES MARKET BY TYPE
5.1 Global Swine Vaccines Revenue by Type
5.1.1 Global Swine Vaccines Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Swine Vaccines Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Swine Vaccines Revenue Market Share by Type (2019-2030)
5.2 Global Swine Vaccines Sales by Type
5.2.1 Global Swine Vaccines Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Swine Vaccines Sales by Type (2019-2030) & (M Doses)
5.2.3 Global Swine Vaccines Sales Market Share by Type (2019-2030)
5.3 Global Swine Vaccines Price by Type
6 SWINE VACCINES MARKET BY APPLICATION
6.1 Global Swine Vaccines Revenue by Application
6.1.1 Global Swine Vaccines Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Swine Vaccines Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Swine Vaccines Revenue Market Share by Application (2019-2030)
6.2 Global Swine Vaccines Sales by Application
6.2.1 Global Swine Vaccines Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Swine Vaccines Sales by Application (2019-2030) & (M Doses)
6.2.3 Global Swine Vaccines Sales Market Share by Application (2019-2030)
6.3 Global Swine Vaccines Price by Application
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Comapny Information
7.1.2 Merck Business Overview
7.1.3 Merck Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Merck Swine Vaccines Product Portfolio
7.1.5 Merck Recent Developments
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Comapny Information
7.2.2 Boehringer Ingelheim Business Overview
7.2.3 Boehringer Ingelheim Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Boehringer Ingelheim Swine Vaccines Product Portfolio
7.2.5 Boehringer Ingelheim Recent Developments
7.3 Jinyu Bio-Technology
7.3.1 Jinyu Bio-Technology Comapny Information
7.3.2 Jinyu Bio-Technology Business Overview
7.3.3 Jinyu Bio-Technology Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Jinyu Bio-Technology Swine Vaccines Product Portfolio
7.3.5 Jinyu Bio-Technology Recent Developments
7.4 CAHIC
7.4.1 CAHIC Comapny Information
7.4.2 CAHIC Business Overview
7.4.3 CAHIC Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 CAHIC Swine Vaccines Product Portfolio
7.4.5 CAHIC Recent Developments
7.5 Tecon
7.5.1 Tecon Comapny Information
7.5.2 Tecon Business Overview
7.5.3 Tecon Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Tecon Swine Vaccines Product Portfolio
7.5.5 Tecon Recent Developments
7.6 Zoetis
7.6.1 Zoetis Comapny Information
7.6.2 Zoetis Business Overview
7.6.3 Zoetis Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Zoetis Swine Vaccines Product Portfolio
7.6.5 Zoetis Recent Developments
7.7 Ceva
7.7.1 Ceva Comapny Information
7.7.2 Ceva Business Overview
7.7.3 Ceva Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Ceva Swine Vaccines Product Portfolio
7.7.5 Ceva Recent Developments
7.8 Hile Bio
7.8.1 Hile Bio Comapny Information
7.8.2 Hile Bio Business Overview
7.8.3 Hile Bio Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Hile Bio Swine Vaccines Product Portfolio
7.8.5 Hile Bio Recent Developments
7.9 Chopper Biology
7.9.1 Chopper Biology Comapny Information
7.9.2 Chopper Biology Business Overview
7.9.3 Chopper Biology Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Chopper Biology Swine Vaccines Product Portfolio
7.9.5 Chopper Biology Recent Developments
7.10 WINSUN
7.10.1 WINSUN Comapny Information
7.10.2 WINSUN Business Overview
7.10.3 WINSUN Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 WINSUN Swine Vaccines Product Portfolio
7.10.5 WINSUN Recent Developments
7.11 Hipra
7.11.1 Hipra Comapny Information
7.11.2 Hipra Business Overview
7.11.3 Hipra Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Hipra Swine Vaccines Product Portfolio
7.11.5 Hipra Recent Developments
7.12 Ringpu Biology
7.12.1 Ringpu Biology Comapny Information
7.12.2 Ringpu Biology Business Overview
7.12.3 Ringpu Biology Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 Ringpu Biology Swine Vaccines Product Portfolio
7.12.5 Ringpu Biology Recent Developments
7.13 ChengDu Tecbond
7.13.1 ChengDu Tecbond Comapny Information
7.13.2 ChengDu Tecbond Business Overview
7.13.3 ChengDu Tecbond Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.13.4 ChengDu Tecbond Swine Vaccines Product Portfolio
7.13.5 ChengDu Tecbond Recent Developments
7.14 DHN
7.14.1 DHN Comapny Information
7.14.2 DHN Business Overview
7.14.3 DHN Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.14.4 DHN Swine Vaccines Product Portfolio
7.14.5 DHN Recent Developments
7.15 CAVAC
7.15.1 CAVAC Comapny Information
7.15.2 CAVAC Business Overview
7.15.3 CAVAC Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.15.4 CAVAC Swine Vaccines Product Portfolio
7.15.5 CAVAC Recent Developments
7.16 Virbac
7.16.1 Virbac Comapny Information
7.16.2 Virbac Business Overview
7.16.3 Virbac Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.16.4 Virbac Swine Vaccines Product Portfolio
7.16.5 Virbac Recent Developments
7.17 HVRI
7.17.1 HVRI Comapny Information
7.17.2 HVRI Business Overview
7.17.3 HVRI Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.17.4 HVRI Swine Vaccines Product Portfolio
7.17.5 HVRI Recent Developments
7.18 Bioveta
7.18.1 Bioveta Comapny Information
7.18.2 Bioveta Business Overview
7.18.3 Bioveta Swine Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.18.4 Bioveta Swine Vaccines Product Portfolio
7.18.5 Bioveta Recent Developments
8 NORTH AMERICA
8.1 North America Swine Vaccines Market Size by Type
8.1.1 North America Swine Vaccines Revenue by Type (2019-2030)
8.1.2 North America Swine Vaccines Sales by Type (2019-2030)
8.1.3 North America Swine Vaccines Price by Type (2019-2030)
8.2 North America Swine Vaccines Market Size by Application
8.2.1 North America Swine Vaccines Revenue by Application (2019-2030)
8.2.2 North America Swine Vaccines Sales by Application (2019-2030)
8.2.3 North America Swine Vaccines Price by Application (2019-2030)
8.3 North America Swine Vaccines Market Size by Country
8.3.1 North America Swine Vaccines Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Swine Vaccines Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Swine Vaccines Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Swine Vaccines Market Size by Type
9.1.1 Europe Swine Vaccines Revenue by Type (2019-2030)
9.1.2 Europe Swine Vaccines Sales by Type (2019-2030)
9.1.3 Europe Swine Vaccines Price by Type (2019-2030)
9.2 Europe Swine Vaccines Market Size by Application
9.2.1 Europe Swine Vaccines Revenue by Application (2019-2030)
9.2.2 Europe Swine Vaccines Sales by Application (2019-2030)
9.2.3 Europe Swine Vaccines Price by Application (2019-2030)
9.3 Europe Swine Vaccines Market Size by Country
9.3.1 Europe Swine Vaccines Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Swine Vaccines Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Swine Vaccines Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Swine Vaccines Market Size by Type
10.1.1 China Swine Vaccines Revenue by Type (2019-2030)
10.1.2 China Swine Vaccines Sales by Type (2019-2030)
10.1.3 China Swine Vaccines Price by Type (2019-2030)
10.2 China Swine Vaccines Market Size by Application
10.2.1 China Swine Vaccines Revenue by Application (2019-2030)
10.2.2 China Swine Vaccines Sales by Application (2019-2030)
10.2.3 China Swine Vaccines Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Swine Vaccines Market Size by Type
11.1.1 Asia Swine Vaccines Revenue by Type (2019-2030)
11.1.2 Asia Swine Vaccines Sales by Type (2019-2030)
11.1.3 Asia Swine Vaccines Price by Type (2019-2030)
11.2 Asia Swine Vaccines Market Size by Application
11.2.1 Asia Swine Vaccines Revenue by Application (2019-2030)
11.2.2 Asia Swine Vaccines Sales by Application (2019-2030)
11.2.3 Asia Swine Vaccines Price by Application (2019-2030)
11.3 Asia Swine Vaccines Market Size by Country
11.3.1 Asia Swine Vaccines Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Swine Vaccines Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Swine Vaccines Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Swine Vaccines Market Size by Type
12.1.1 MEALA Swine Vaccines Revenue by Type (2019-2030)
12.1.2 MEALA Swine Vaccines Sales by Type (2019-2030)
12.1.3 MEALA Swine Vaccines Price by Type (2019-2030)
12.2 MEALA Swine Vaccines Market Size by Application
12.2.1 MEALA Swine Vaccines Revenue by Application (2019-2030)
12.2.2 MEALA Swine Vaccines Sales by Application (2019-2030)
12.2.3 MEALA Swine Vaccines Price by Application (2019-2030)
12.3 MEALA Swine Vaccines Market Size by Country
12.3.1 MEALA Swine Vaccines Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Swine Vaccines Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Swine Vaccines Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Swine Vaccines Value Chain Analysis
13.1.1 Swine Vaccines Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Swine Vaccines Production Mode & Process
13.2 Swine Vaccines Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Swine Vaccines Distributors
13.2.3 Swine Vaccines Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
